Landscapes / Companies
SK Life Science, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
3
in active trials · 7 in all
Trials
3 active
21 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | 31 Jan 2027Phase 3 trial completes | |||
| Next date | 31 Jan 2027 · Phase 3 trial completes | ||||
| Also tested for | Focal Onset Seizure, Epilepsy, Generalized and 2 more | ||||
| Open drug page | |||||
— |
Phase 3 | Feb 2027Phase 3 trial completes | |||
| Next date | Feb 2027 · Phase 3 trial completes | ||||
| Also tested for | Seizures, Lennox Gastaut Syndrome | ||||
| Open drug page | |||||
— |
Phase 1 | Jul 2030Phase 1 trial completes | |||
| Next date | Jul 2030 · Phase 1 trial completes | ||||
| Also tested for | Selected Advanced Solid Tumors, Colorectal Cancer (CRC) and 5 more | ||||
| Open drug page | |||||
About
- No active trial
- Cenobamate Suspension Fed, Cenobomate Suspension Fasted, SKL24741, SKL27969
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021